Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study

• Adeyinka Charles Adejumo,

  Affiliations Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America, Biomedical Engineering & Biotechnology Program, University of Massachusetts Lowell, Lowell Massachusetts, United States of America

  ⨯
• Samson Alliu,

  Affiliation Department of Medicine, Maimonides Medical Center, Brooklyn, New York, United States of America

  ⨯
• Tokunbo Opeyemi Ajayi,

  Affiliation Johns Hopkins Medicine, Howard County General Hospital, Columbia, Maryland, United States of America

  ⨯
• Kelechi Lauretta Adejumo,

  Affiliation Public Health Program, University of Massachusetts Lowell, Lowell, United States of America

  ⨯
• Oluwole Muyiwa Adegbala,

  Affiliation Department of Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey, United States of America

  ⨯
• Nnaemeka Egbuna Onyeakusi,

  Affiliation Department of Pediatrics, Bronx-Lebanon Hospital Center, Bronx, New York, United States of America

  ⨯
• Akintunde Micheal Akinjero,

  Affiliation Department of Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey, United States of America

  ⨯
• Modupeoluwa Durojaiye,

  Affiliation Department of Maternal and Child Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Terence Ndonyi Bukong

  * E-mail: terencendonyi.bukong@iaf.inrs.ca

  Affiliations Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America, INRS-Institut Armand-Frappier, Institut National de la Reserche Scientifique, Laval, Quebec, Canada

  http://orcid.org/0000-0003-3898-0617

  ⨯